Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Grimaldi

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 14, 2014
Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade gliomaPierina Navarria, Giacomo Reggiori, Federico Pessina, et al.
Radiology|January 24, 2018
Brain Gliomas: Multicenter Standardized Assessment of Dynamic Contrast-enhanced and Dynamic Susceptibility Contrast MR ImagesNicoletta Anzalone, Antonella Castellano, Marcello Cadioli, et al.
World Neurosurgery|February 25, 2019
Lower Grade Gliomas: Relationships Between Metabolic and Structural Imaging with Grading and Molecular FactorsMarco Riva, Egesta Lopci, Antonella Castellano, et al.
Oncotarget|October 6, 2017
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II studyPierina Navarria, Federico Pessina, Stefano Tomatis, et al.
La Radiologia Medica|May 5, 2023
CT-based radiomics can identify physiological modifications of bone structure related to subjects' age and sexRiccardo Levi, Federico Garoli, Massimiliano Battaglia, et al.
Journal of Neurosurgery|September 4, 2020
Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large seriesPierina Navarria, Federico Pessina, Elena Clerici, et al.
Frontiers in Neuroscience|April 17, 2020
fMRI-Targeted High-Angular Resolution Diffusion MR Tractography to Identify Functional Language Tracts in Healthy Controls and Glioma PatientsFrancesco Sanvito, Eduardo Caverzasi, Marco Riva, et al.
Neuro-Oncology|April 2, 2025
AI differentiates radionecrosis from true progression in brain metastasis upon stereotactic radiosurgery: analysis of 124 histologically assessed lesionsGaia Ressa, Riccardo Levi, Giovanni Savini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 23, 2017
Prognostic value of molecular and imaging biomarkers in patients with supratentorial gliomaEgesta Lopci, Marco Riva, Laura Olivari, et al.
Molecular Genetics and Metabolism Reports|March 4, 2016
Enzymatic replacement therapy for Hunter disease: Up to 9 years experience with 17 patientsRossella Parini, Miriam Rigoldi, Lucia Tedesco, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 14, 2014
Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade gliomaPierina Navarria, Giacomo Reggiori, Federico Pessina, et al.
Radiology|January 24, 2018
Brain Gliomas: Multicenter Standardized Assessment of Dynamic Contrast-enhanced and Dynamic Susceptibility Contrast MR ImagesNicoletta Anzalone, Antonella Castellano, Marcello Cadioli, et al.
World Neurosurgery|February 25, 2019
Lower Grade Gliomas: Relationships Between Metabolic and Structural Imaging with Grading and Molecular FactorsMarco Riva, Egesta Lopci, Antonella Castellano, et al.
Oncotarget|October 6, 2017
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II studyPierina Navarria, Federico Pessina, Stefano Tomatis, et al.
La Radiologia Medica|May 5, 2023
CT-based radiomics can identify physiological modifications of bone structure related to subjects' age and sexRiccardo Levi, Federico Garoli, Massimiliano Battaglia, et al.
Journal of Neurosurgery|September 4, 2020
Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large seriesPierina Navarria, Federico Pessina, Elena Clerici, et al.
Frontiers in Neuroscience|April 17, 2020
fMRI-Targeted High-Angular Resolution Diffusion MR Tractography to Identify Functional Language Tracts in Healthy Controls and Glioma PatientsFrancesco Sanvito, Eduardo Caverzasi, Marco Riva, et al.
Neuro-Oncology|April 2, 2025
AI differentiates radionecrosis from true progression in brain metastasis upon stereotactic radiosurgery: analysis of 124 histologically assessed lesionsGaia Ressa, Riccardo Levi, Giovanni Savini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 23, 2017
Prognostic value of molecular and imaging biomarkers in patients with supratentorial gliomaEgesta Lopci, Marco Riva, Laura Olivari, et al.
Molecular Genetics and Metabolism Reports|March 4, 2016
Enzymatic replacement therapy for Hunter disease: Up to 9 years experience with 17 patientsRossella Parini, Miriam Rigoldi, Lucia Tedesco, et al.
Pageof 4